PROGENITY, INC.

Profile

Company Names

PROGENITY, INC.
ASCENDANT MDX, INC.

Addresses

4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO, CA 92122

4330 LA JOLLA DRIVE, SUITE 200, SAN DIEGO, CA 92122

2173 SALK AVENUE, SUITE 150, CARLSBAD, CA 92008

Phone Numbers

760-494-1555

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$141,625,000.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2020-04-03 
$9,999,999.00 
$59,999,998.00 
$49,999,999.00 
Equity 
6
2019-11-12 
$31,124,999.00 
$105,502,086.00 
$74,377,087.00 
Equity 
5
2019-08-27 
$25,000,002.00 
$100,000,000.00 
$74,999,998.00 
Equity 
4
2017-10-27 
$50,000,000.00 
$55,000,001.00 
$5,000,001.00 
Equity 
3
2016-08-08 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
2
2015-06-08 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2013-06-12 
$13,500,000.00 
$13,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUMIT 
 
AGGARWAL 
EXECUTIVE OFFICER
PROGENITY, INC.   |  ZIKANI THERAPEUTICS, INC.
JEFFREY 
 
ALTER 
DIRECTOR
PROGENITY, INC.   |  WP CITYMD TOPCO LLC   |  ANOMALY INSIGHTS, INC.
JOHN 
 
BIGALKE 
DIRECTOR
PROGENITY, INC.
ERIC 
 
D-ESPARBES 
EXECUTIVE OFFICER
PROGENITY, INC.
JEFFREY 
 
FERRELL 
DIRECTOR
PROGENITY, INC.   |  SECURA BIO HOLDINGS, INC.
JEFFREY 
A. 
FERRELL 
DIRECTOR
ATHYRIUM PARTNERS, LP   |  LPATH, INC   |  ATHYRIUM OPPORTUNITIES FUND II-B MASTER LP   |  ATHYRIUM OPPORTUNITIES FUND II (NON-US) LP   |  ATHYRIUM OPPORTUNITIES FUND II LP   |  PROGENITY, INC.   |  ATHYRIUM OPPORTUNITIES FUND III (NON-US) B LP   |  ATHYRIUM OPPORTUNITIES FUND III (NON-US) A LP   |  ATHYRIUM OPPORTUNITIES FUND III LP   |  ATHYRIUM HEALTHCARE STRATEGIC INCOME + GROWTH IDF LLC   |  ATHYRIUM OPPORTUNITIES FUND IV (NON-US) LP   |  ATHYRIUM OPPORTUNITIES FUND IV LP   |  ATHYRIUM OPPORTUNITIES FUND IV MASTER (NON-US) LP   |  ATHYRIUM OT LP
ERIC 
 
FOX 
EXECUTIVE OFFICER
ASCENDANT MDX, INC.   |  PROGENITY, INC.
PAUL 
 
HAWRAN 
PROMOTER
ASCENDANT MDX, INC.   |  PROGENITY, INC.
BRIAN 
 
KOTZIN 
DIRECTOR
PROGENITY, INC.   |  KYVERNA THERAPEUTICS, INC.
CLARKE 
 
NEUMANN 
EXECUTIVE OFFICER
SEQUENOM INC   |  PROGENITY, INC.
SAMUEL 
 
NUSSBAUM 
DIRECTOR
PROGENITY, INC.   |  ABLE CHANNEL, INC.
LYNNE 
 
POWELL 
DIRECTOR
PROGENITY, INC.
HOWARD 
 
SLUTSKY 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
ASCENDANT MDX, INC.   |  PROGENITY, INC.   |  DIAGNOSTIC SUPPORT SERVICES, INC.
HARRY 
 
STYLLI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CELL MDX, LLC   |  ASCENDANT MDX, INC.   |  PROGENITY, INC.   |  KARNELIAN X, INC.
HARRY 
G. 
STYLLI 
EXECUTIVE OFFICER, DIRECTOR
PROGENITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-27
D/A
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2020-04-03 
2020-04-20
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2020-04-03 
2019-11-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-12 
2019-09-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-27 
2017-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-27 
2016-08-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-08 
2015-06-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-08 
2013-06-28
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-12 
2013-06-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#